In vivo dopamine receptor assessment for clinical studies using positron emission tomography
- 15 July 1987
- journal article
- editorial
- Published by Elsevier in Biochemical Pharmacology
- Vol. 36 (14), 2241-2250
- https://doi.org/10.1016/0006-2952(87)90586-7
Abstract
No abstract availableThis publication has 94 references indexed in Scilit:
- Preparation of 11C-labelled raclopride, a new potent dopamine receptor antagonist: Preliminary PET studies of cerebral dopamine receptors in the monkeyThe International Journal of Applied Radiation and Isotopes, 1985
- Two dopamine receptors: Biochemistry, physiology and pharmacologyLife Sciences, 1984
- Comparison in animal models of 18F-spiroperidol and 18F-haloperidol: Potential agents for imaging the dopamine receptorLife Sciences, 1983
- Low-dose apomorphine reduces serum homovanillic acid concentrations in schizophrenic patientsLife Sciences, 1982
- Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptorsEuropean Journal of Pharmacology, 1981
- Synthesis of a 11C-labelled neuroleptic drug: PimozideThe International Journal of Applied Radiation and Isotopes, 1980
- Characterization of specific in vivo binding of neuroleptic drugs in rat brainLife Sciences, 1978
- Dopamine receptor binding in vivo: The feasibility of autoradiographic studiesLife Sciences, 1978
- On the origin of homovanillic acid (HVA) in the cerebrospinal fluidJournal of Neural Transmission, 1973
- Effects of chlorpromazine, haloperidol and reserpine on the levels of phenolic acids in rabbit corpus striatumLife Sciences, 1964